SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-031187
Filing Date
2009-05-11
Accepted
2009-05-11 06:03:15
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a09-11066_110q.htm 10-Q 643096
2 EX-10.71 a09-11066_1ex10d71.htm EX-10.71 112505
3 EX-31.1 a09-11066_1ex31d1.htm EX-31.1 12293
4 EX-31.2 a09-11066_1ex31d2.htm EX-31.2 12410
5 EX-32 a09-11066_1ex32.htm EX-32 7891
  Complete submission text file 0001104659-09-031187.txt   789702
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 09812568
SIC: 2834 Pharmaceutical Preparations